David Vining

3PUBLICATIONS
50CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 10, 2025
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.

Apostolia M Tsimberidou, David J Vining, Sukeshi P Arora

|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.

Apostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson

Pageof 1

Frequent Collaborators

2 joint publications

Apostolia M Tsimberidou

1 joint publications

Gary J Whitman

1 joint publications

Sukeshi P Arora

1 joint publications

Sofia de Achaval